![Ignacio Faus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ignacio Faus
Director/Board Member at
NFL BIOSCIENCES
Net worth: 12 890 $ as of 29/09/2026
Profile
Dr. Ignacio Faus is a Deputy Chief Executive Officer & Director at NFL Biosciences SAS and an Advisor at DRI Healthcare.
He is on the Board of Directors at NFL Biosciences SAS. Dr. Faus was previously employed as a Chief Executive Officer by Mologen AG, a Chief Executive Officer by Palau Pharma SA, a Manager-Business Development by J.
Uriach y Cia SA, a Chief Executive Officer & Director by Genmedica Therapeutics SL, and an Executive Director by Sage Healthcare Ltd. He received his MBA from Kellogg School of Management and a doctorate degree from Indiana University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
DRI Healthcare Trust
 DRI Healthcare Trust Investment Trusts/Mutual FundsMiscellaneous Operates as a royalty trust 0% | 12/11/2025 | 1,000 ( 0% ) | 12 890 $ | 29/09/2026 |
Ignacio Faus active positions
| Companies | Position | Start |
|---|---|---|
| NFL BIOSCIENCES | Director/Board Member | 16/10/2024 |
DRI Healthcare
 DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. | Consultant / Advisor | - |
Former positions of Ignacio Faus
| Companies | Position | End |
|---|---|---|
| MOLOGEN AG | Chief Executive Officer | 30/03/2019 |
Palau Pharma SA
 Palau Pharma SA BiotechnologyHealth Technology Provides research and development services to the pharmaceutical sector | Chief Executive Officer | 31/12/2012 |
Noucor Health SA
 Noucor Health SA Miscellaneous Commercial ServicesCommercial Services Engages in research, development and manufacturing of medicines & food supplements | Corporate Officer/Principal | 31/10/2006 |
Sage Healthcare Ltd.
 Sage Healthcare Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services to the healthcare industry | Director/Board Member | - |
Genmedica Therapeutics SL
 Genmedica Therapeutics SL BiotechnologyHealth Technology Engages in the research and development of treatments for metabolic disorders | Chief Executive Officer | - |
Education of Ignacio Faus
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
92
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
DRI Healthcare
DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. | Finance |
MOLOGEN AG
 MOLOGEN AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for the treatment of infectious diseases | Health Technology |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Noucor Health SA
Noucor Health SA Miscellaneous Commercial ServicesCommercial Services Engages in research, development and manufacturing of medicines & food supplements | Commercial Services |
Genmedica Therapeutics SL
Genmedica Therapeutics SL BiotechnologyHealth Technology Engages in the research and development of treatments for metabolic disorders | Health Technology |
Palau Pharma SA
Palau Pharma SA BiotechnologyHealth Technology Provides research and development services to the pharmaceutical sector | Health Technology |
Sage Healthcare Ltd.
Sage Healthcare Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services to the healthcare industry | Commercial Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NFL Biosciences SAS
 NFL Biosciences SAS BiotechnologyHealth Technology Operates as a biotechnology company that develops botanical treatments for addictions | Health Technology |
- Stock Market
- Insiders
- Ignacio Faus
